Contec Medical SystemsLtd

SZSE:300869 Stock Report

Mkt Cap: CN¥10.6b

We’ve recently updated our valuation analysis.

Contec Medical SystemsLtd Valuation

Is 300869 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300869?

Other financial metrics that can be useful for relative valuation.

300869 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue16x
Enterprise Value/EBITDA88.8x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 300869's PE Ratio compare to its peers?

The above table shows the PE ratio for 300869 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average43.2x
600587 Shinva Medical Instrument
19.2x17.1%CN¥10.3b
300206 Edan Instruments
45.6xn/aCN¥7.8b
600055 Beijing Wandong Medical TechnologyLtd
86.5x28.3%CN¥14.4b
603301 Zhende Medical
21.4x18.4%CN¥12.2b
300869 Contec Medical SystemsLtd
44.3xn/aCN¥10.6b

Price-To-Earnings vs Peers: 300869 is expensive based on its Price-To-Earnings Ratio (44.3x) compared to the peer average (43.2x).


Price to Earnings Ratio vs Industry

How does 300869's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a24.4%
n/an/an/a

Price-To-Earnings vs Industry: 300869 is expensive based on its Price-To-Earnings Ratio (44.3x) compared to the CN Medical Equipment industry average (36.8x)


Price to Earnings Ratio vs Fair Ratio

What is 300869's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300869 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio44.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 300869's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 300869 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300869 (CN¥26.28) is trading above our estimate of fair value (CN¥5.46)

Significantly Below Fair Value: 300869 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies